Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. ARS Other Annual Report to Security Holders
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 10-Q Report Quarterly Report
  9. 8-K Event Bylaws or fiscal year change
  10. DEF 14C Other DEF 14C
  11. PRE 14C Other PRE 14C
  12. EFFECT Other Notice of Effectiveness
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-3/A Offering Registration Statement
  15. 8-K Event Delisting notice
  16. UPLOAD Other SEC-generated Letter
  17. S-3 Offering Registration Statement
  18. 10-K Report Annual Report
  19. 8-K Event Regulation FD disclosure
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 2 of 77 · 1,525 filings